Niagen Bioscience GAAP EPS of -$0.01 misses by $0.01, revenue of $27.2M misses by $4.7M
Open the sourceReported by Seeking Alpha, seekingalpha.com, 4 November 2026
40Impact 40 of 100, routine
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at seekingalpha.com.
Named in this story
Niagen Bioscience